Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

NCT00412854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Diphtheria
Acellular Pertussis

Interventions

BIOLOGICAL: Infanrix™/Hib
BIOLOGICAL: Infanrix
BIOLOGICAL: Hiberix

Sponsor

GlaxoSmithKline